Litman Gregory Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$1.11M Hold
44,398
– – 0.08% 80
2025
Q3
$1.13M Buy
+44,398
New +$1.1M 0.08% 76
2023
Q2
– Sell
-10,874
Closed -$444K – 105
2023
Q1
$444K Buy
+10,874
New +$470K 0.17% 22
2021
Q2
– Sell
-2,170
Closed -$79K – 155
2021
Q1
$79K Hold
2,170
– – 0.02% 83
2020
Q4
$80K Sell
2,170
-117
-5% -$4.29K 0.01% 83
2020
Q3
$80K Hold
2,287
– – 0.02% 78
2020
Q2
$71K Hold
2,287
– – 0.02% 81
2020
Q1
$71K Sell
2,287
-2,635
-54% -$89.8K 0.02% 70
2019
Q4
$183K Buy
4,922
+2,002
+69% +$71.3K 0.04% 51
2019
Q3
$100K Sell
2,920
-555
-16% -$20.2K 0.02% 64
2019
Q2
$143K Buy
3,475
+1,188
+52% +$47.2K 0.04% 54
2019
Q1
$92K Hold
2,287
– – 0.03% 56
2018
Q4
$95K Hold
2,287
– – 0.03% 56
2018
Q3
$96K Hold
2,287
– – 0.03% 49
2018
Q2
$79K Hold
2,287
– – 0.03% 45
2018
Q1
$77K Buy
2,287
+1,233
+117% +$42.4K 0.03% 68
2017
Q4
$36K Hold
1,054
– – 0.01% 58
2017
Q3
$36K Hold
1,054
– – 0.02% 57
2017
Q2
$34K Sell
1,054
-1,054
-50% -$33.2K 0.02% 40
2017
Q1
$68K Buy
2,108
+1,054
+100% +$33.2K 0.04% 35
2016
Q4
$32K Hold
1,054
– – 0.02% 37
2016
Q3
$34K Hold
1,054
– – 0.02% 33
2016
Q2
$35K Hold
1,054
– – 0.03% 31
2016
Q1
$30K Buy
+1,054
New +$30.1K 0.02% 36

Other funds holding PFE

Litman Gregory Wealth Management's PFE Position: Q4 2025 in Review

Litman Gregory Wealth Management held its Pfizer (PFE) position steady in Q4 2025 at 44,398 shares worth $1.11M. The position accounts for 0.08% of the portfolio, ranked #80.

Litman Gregory Wealth Management first reported a position in PFE in Q1 2016 and has held it in 24 quarters since. The position peaked at $1.13M in Q3 2025. 2,923 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • Litman Gregory Wealth Management held 44,398 shares of Pfizer worth $1.11M as of Q4 2025.
  • Litman Gregory Wealth Management left its Pfizer share count unchanged in Q4 2025.
  • Pfizer made up 0.08% of Litman Gregory Wealth Management's portfolio in Q4 2025, its #80 holding.
  • Litman Gregory Wealth Management first reported a position in Pfizer in Q1 2016 and has held it in 24 quarters since.
  • Litman Gregory Wealth Management's Pfizer position peaked at $1.13M in Q3 2025.
  • 2,923 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Litman Gregory Wealth Management's 13F filing for Q4 2025, filed 12 Feb 2026.